Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | EYA2 | O00167 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentetic Acid SCHEMBL3798491 | 1.00 | TDP1 (0.38) | TDP1BLMPMP22KDM4ELMNA | |
| Pentetic Acid SCHEMBL3797811 | 1.00 | TDP1 (0.38) | TDP1BLMPMP22KDM4ELMNA | |
| Edetic Acid SCHEMBL3799764 | 0.99 | TDP1 (0.36) | TDP1BLMPMP22KDM4ELMNA | |
| Edetic Acid SCHEMBL3796431 | 0.99 | TDP1 (0.36) | TDP1BLMPMP22KDM4ELMNA | |
| Nitrilotriacetic Acid SCHEMBL3801112 | 0.94 | — | — | |
| Edetic Acid SCHEMBL4169915 | 0.91 | KDM4E (0.31) | TDP1KDM4EALOX15EYA2APP | |
| Pentetic Acid SCHEMBL3802223 | 0.85 | TDP1 (0.33) | TDP1BLMPMP22KDM4ELMNA | |
| Edetic Acid SCHEMBL3802209 | 0.83 | TDP1 (0.32) | TDP1BLMPMP22KDM4ELMNA | |
| Pentetic Acid SCHEMBL3799811 | 0.82 | TDP1 (0.38) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL39209 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060264345-A1 | Stabilized body care products, household products, textiles and fabrics | BASF SE (DE) | 2006-11-23 | — | — | US | claimed |
| US-8216596-B2 | 4-Hydroxy-1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidine, citric acid and a body care product; hindered amine salt compounds provide outstanding protection against light-induced fading | BASF SE (DE) | 2012-07-10 | — | — | US | disclosed |
| US-20090092561-A1 | Body-care and household products and compositions comprising specific sulfur-containing compounds | BASF SE (DE) | 2009-04-09 | — | — | US | disclosed |
| US-20060264345-A1 | Stabilized body care products, household products, textiles and fabrics | BASF SE (DE) | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264345-A1 | Stabilized body care products, household products, textiles and fabrics | DSC1, CUTA, DSG1 | TDP1 963/4885BLM 981/4885PMP22 1048/4885 |
| US-20090092561-A1 | Body-care and household products and compositions comprising specific sulfur-containing compounds | DSC1, SCLY, DSG1 | TDP1 1610/4885BLM 1668/4885PMP22 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.